Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC

K. D. Joode, H. J. M. Groen, A. A. M. van der Veldt, K. P. M. Suijkerbuijk, J. W. B. de Groot, R. de Wijn, D. P. Hurkmans, D. M. A. van den Heuvel, K. Schmidt, J. P. Groten, E. M. E. Verdegaal, S. H. van der Burg, M. M. van den Heuvel, J. G. J. V. Aerts, E. Kapiteijn, R. H. Mathijssen

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S788-S788
Number of pages1
JournalAnnals of Oncology
Volume31
DOIs
Publication statusPublished - Sep-2020
EventESMO Virtual Congress -
Duration: 19-Sep-202018-Oct-2020

Cite this